Bronchoalveolar lavage fluid evaluation in rheumatoid arthritis

Joe GN Garcia, N. Parhami, D. Killam, B. A. Keogh

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Rheumatoid arthritis (RA), a systemic disorder of unknown cause, is associated with a variety of well-recognized pulmonary abnormalities including interstitial lung disease. To investigate possible pathogenic events in this disorder, we performed bronchoalveolar lavage (BAL) in 24 patients with classic or definite RA. Using radiographic and physiologic parameters as well as BAL cell differentials, 3 distinct groups emerged. Group I consisted of 9 patients with evidence of clinical interstitial lung involvement. Group II consisted of 5 patients without evidence of clinical interstitial lung disease (normal chest roentgenogram and functional testing) but who had abnormal BAL cellular differentials. The 10 remaining patients (Group III) had no evidence of clinical interstitial lung disease and had normal BAL cell differentials. Bronchoalveolar lavage in Group I had a significantly increased percentage of neutrophils (12.4 ± 4.2; p < 0.05) compared with group II (2.4 ± 0.8) and Group III (2.9 ± 0.6). All patients in Group II had elevated BAL lymphocytes (24.4 ± 6.4) compared with Group I (10.1 ± 3.8; p > 0.05) and Group III (5.4 ± 0.7; p < 0.01). Both Groups I and II had detectable IgM in BAL (0.02 ± 0.01 and 0.04 ± 0.02 mg/mg of albumin, respectively), whereas Group III patients and normal control subjects did not (p < 0.01). There was a marked reduction in BAL T-lymphocyte Leu 3/Leu 2A (helper/suppressor) cell ratios in Group I (0.92 ± 0.02; p < 0.05) compared with Group II (2.6 ± 0.6) and Group III (1.6 ± 0.1). This decreased BAL T-lymphocyte Leu 3/Leu 2A ratio in group I was not reflected in the peripheral blood of this group where the Leu 3/Leu 2A ratio in Group I was not reflected in the peripheral blood of this group where the Leu 3/Leu 2A ratio was 1.95 ± 0.2 (p < 0.05 compared with BAL). Peripheral blood Leu 3/Leu 2A ratios were not significantly different from BAL ratios in Group II (3.8 ± 0.5) and Group III (2.1 ± 0.2) (p > 0.05, both comparisons), but the value for group II was significantly greater than those for Groups I and III (p < 0.05). These findings of lower respiratory tract abnormalities in a group of patients with RA with and without established interstitial lung disease suggest that BAL may be a useful tool for studying potential pathogenic mechanisms in rheumatoid lung disease.

Original languageEnglish (US)
Pages (from-to)450-454
Number of pages5
JournalAmerican Review of Respiratory Disease
Volume133
Issue number3
StatePublished - 1986
Externally publishedYes

Fingerprint

Bronchoalveolar Lavage Fluid
Bronchoalveolar Lavage
Rheumatoid Arthritis
Interstitial Lung Diseases
Lung
Respiratory System
Lung Diseases
Neutrophils
Thorax

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Bronchoalveolar lavage fluid evaluation in rheumatoid arthritis. / Garcia, Joe GN; Parhami, N.; Killam, D.; Keogh, B. A.

In: American Review of Respiratory Disease, Vol. 133, No. 3, 1986, p. 450-454.

Research output: Contribution to journalArticle

Garcia, JGN, Parhami, N, Killam, D & Keogh, BA 1986, 'Bronchoalveolar lavage fluid evaluation in rheumatoid arthritis', American Review of Respiratory Disease, vol. 133, no. 3, pp. 450-454.
Garcia, Joe GN ; Parhami, N. ; Killam, D. ; Keogh, B. A. / Bronchoalveolar lavage fluid evaluation in rheumatoid arthritis. In: American Review of Respiratory Disease. 1986 ; Vol. 133, No. 3. pp. 450-454.
@article{24c146ff6a614a138b5f3aaa58ee3b41,
title = "Bronchoalveolar lavage fluid evaluation in rheumatoid arthritis",
abstract = "Rheumatoid arthritis (RA), a systemic disorder of unknown cause, is associated with a variety of well-recognized pulmonary abnormalities including interstitial lung disease. To investigate possible pathogenic events in this disorder, we performed bronchoalveolar lavage (BAL) in 24 patients with classic or definite RA. Using radiographic and physiologic parameters as well as BAL cell differentials, 3 distinct groups emerged. Group I consisted of 9 patients with evidence of clinical interstitial lung involvement. Group II consisted of 5 patients without evidence of clinical interstitial lung disease (normal chest roentgenogram and functional testing) but who had abnormal BAL cellular differentials. The 10 remaining patients (Group III) had no evidence of clinical interstitial lung disease and had normal BAL cell differentials. Bronchoalveolar lavage in Group I had a significantly increased percentage of neutrophils (12.4 ± 4.2; p < 0.05) compared with group II (2.4 ± 0.8) and Group III (2.9 ± 0.6). All patients in Group II had elevated BAL lymphocytes (24.4 ± 6.4) compared with Group I (10.1 ± 3.8; p > 0.05) and Group III (5.4 ± 0.7; p < 0.01). Both Groups I and II had detectable IgM in BAL (0.02 ± 0.01 and 0.04 ± 0.02 mg/mg of albumin, respectively), whereas Group III patients and normal control subjects did not (p < 0.01). There was a marked reduction in BAL T-lymphocyte Leu 3/Leu 2A (helper/suppressor) cell ratios in Group I (0.92 ± 0.02; p < 0.05) compared with Group II (2.6 ± 0.6) and Group III (1.6 ± 0.1). This decreased BAL T-lymphocyte Leu 3/Leu 2A ratio in group I was not reflected in the peripheral blood of this group where the Leu 3/Leu 2A ratio in Group I was not reflected in the peripheral blood of this group where the Leu 3/Leu 2A ratio was 1.95 ± 0.2 (p < 0.05 compared with BAL). Peripheral blood Leu 3/Leu 2A ratios were not significantly different from BAL ratios in Group II (3.8 ± 0.5) and Group III (2.1 ± 0.2) (p > 0.05, both comparisons), but the value for group II was significantly greater than those for Groups I and III (p < 0.05). These findings of lower respiratory tract abnormalities in a group of patients with RA with and without established interstitial lung disease suggest that BAL may be a useful tool for studying potential pathogenic mechanisms in rheumatoid lung disease.",
author = "Garcia, {Joe GN} and N. Parhami and D. Killam and Keogh, {B. A.}",
year = "1986",
language = "English (US)",
volume = "133",
pages = "450--454",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "3",

}

TY - JOUR

T1 - Bronchoalveolar lavage fluid evaluation in rheumatoid arthritis

AU - Garcia, Joe GN

AU - Parhami, N.

AU - Killam, D.

AU - Keogh, B. A.

PY - 1986

Y1 - 1986

N2 - Rheumatoid arthritis (RA), a systemic disorder of unknown cause, is associated with a variety of well-recognized pulmonary abnormalities including interstitial lung disease. To investigate possible pathogenic events in this disorder, we performed bronchoalveolar lavage (BAL) in 24 patients with classic or definite RA. Using radiographic and physiologic parameters as well as BAL cell differentials, 3 distinct groups emerged. Group I consisted of 9 patients with evidence of clinical interstitial lung involvement. Group II consisted of 5 patients without evidence of clinical interstitial lung disease (normal chest roentgenogram and functional testing) but who had abnormal BAL cellular differentials. The 10 remaining patients (Group III) had no evidence of clinical interstitial lung disease and had normal BAL cell differentials. Bronchoalveolar lavage in Group I had a significantly increased percentage of neutrophils (12.4 ± 4.2; p < 0.05) compared with group II (2.4 ± 0.8) and Group III (2.9 ± 0.6). All patients in Group II had elevated BAL lymphocytes (24.4 ± 6.4) compared with Group I (10.1 ± 3.8; p > 0.05) and Group III (5.4 ± 0.7; p < 0.01). Both Groups I and II had detectable IgM in BAL (0.02 ± 0.01 and 0.04 ± 0.02 mg/mg of albumin, respectively), whereas Group III patients and normal control subjects did not (p < 0.01). There was a marked reduction in BAL T-lymphocyte Leu 3/Leu 2A (helper/suppressor) cell ratios in Group I (0.92 ± 0.02; p < 0.05) compared with Group II (2.6 ± 0.6) and Group III (1.6 ± 0.1). This decreased BAL T-lymphocyte Leu 3/Leu 2A ratio in group I was not reflected in the peripheral blood of this group where the Leu 3/Leu 2A ratio in Group I was not reflected in the peripheral blood of this group where the Leu 3/Leu 2A ratio was 1.95 ± 0.2 (p < 0.05 compared with BAL). Peripheral blood Leu 3/Leu 2A ratios were not significantly different from BAL ratios in Group II (3.8 ± 0.5) and Group III (2.1 ± 0.2) (p > 0.05, both comparisons), but the value for group II was significantly greater than those for Groups I and III (p < 0.05). These findings of lower respiratory tract abnormalities in a group of patients with RA with and without established interstitial lung disease suggest that BAL may be a useful tool for studying potential pathogenic mechanisms in rheumatoid lung disease.

AB - Rheumatoid arthritis (RA), a systemic disorder of unknown cause, is associated with a variety of well-recognized pulmonary abnormalities including interstitial lung disease. To investigate possible pathogenic events in this disorder, we performed bronchoalveolar lavage (BAL) in 24 patients with classic or definite RA. Using radiographic and physiologic parameters as well as BAL cell differentials, 3 distinct groups emerged. Group I consisted of 9 patients with evidence of clinical interstitial lung involvement. Group II consisted of 5 patients without evidence of clinical interstitial lung disease (normal chest roentgenogram and functional testing) but who had abnormal BAL cellular differentials. The 10 remaining patients (Group III) had no evidence of clinical interstitial lung disease and had normal BAL cell differentials. Bronchoalveolar lavage in Group I had a significantly increased percentage of neutrophils (12.4 ± 4.2; p < 0.05) compared with group II (2.4 ± 0.8) and Group III (2.9 ± 0.6). All patients in Group II had elevated BAL lymphocytes (24.4 ± 6.4) compared with Group I (10.1 ± 3.8; p > 0.05) and Group III (5.4 ± 0.7; p < 0.01). Both Groups I and II had detectable IgM in BAL (0.02 ± 0.01 and 0.04 ± 0.02 mg/mg of albumin, respectively), whereas Group III patients and normal control subjects did not (p < 0.01). There was a marked reduction in BAL T-lymphocyte Leu 3/Leu 2A (helper/suppressor) cell ratios in Group I (0.92 ± 0.02; p < 0.05) compared with Group II (2.6 ± 0.6) and Group III (1.6 ± 0.1). This decreased BAL T-lymphocyte Leu 3/Leu 2A ratio in group I was not reflected in the peripheral blood of this group where the Leu 3/Leu 2A ratio in Group I was not reflected in the peripheral blood of this group where the Leu 3/Leu 2A ratio was 1.95 ± 0.2 (p < 0.05 compared with BAL). Peripheral blood Leu 3/Leu 2A ratios were not significantly different from BAL ratios in Group II (3.8 ± 0.5) and Group III (2.1 ± 0.2) (p > 0.05, both comparisons), but the value for group II was significantly greater than those for Groups I and III (p < 0.05). These findings of lower respiratory tract abnormalities in a group of patients with RA with and without established interstitial lung disease suggest that BAL may be a useful tool for studying potential pathogenic mechanisms in rheumatoid lung disease.

UR - http://www.scopus.com/inward/record.url?scp=0022624633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022624633&partnerID=8YFLogxK

M3 - Article

C2 - 3485395

AN - SCOPUS:0022624633

VL - 133

SP - 450

EP - 454

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 3

ER -